Related Experiment Video
Updated: Jul 18, 2026

Measurement of Tumor T2* Relaxation Times after Iron Oxide Nanoparticle Administration
Published on: May 19, 2023
Iron overload in the liver diagnostic and quantification.
Jose M Alústiza1, Agustin Castiella, Maria D De Juan
1Osatek SA, P Dr. Beguiristain 109, 20014, San Sebastian, Guipuzcoa, Spain. jmalustiza@osatek.es
Hereditary Hemochromatosis diagnosis often requires hepatic iron quantification when genetic tests are negative. Magnetic Resonance offers a non-invasive alternative to biopsy, but standardization is needed for reliable results.
Area of Science:
- Medical Diagnostics
- Gastroenterology
- Radiology
Background:
- Hereditary Hemochromatosis is a common iron overload disorder.
- Genetic testing aids diagnosis but has limitations.
- Hepatic iron quantification is crucial for definitive diagnosis in some cases.
Purpose of the Study:
- To review the current state of non-invasive hepatic iron quantification using Magnetic Resonance (MR).
- To address the lack of consensus on MR techniques and reproducibility.
- To propose future directions for standardizing MR-based iron quantification.
Main Methods:
- Review of existing studies on MR for hepatic iron quantification.
- Analysis of challenges in technique standardization and inter-machine reproducibility.
- Discussion of current diagnostic pathways including genetic testing and liver biopsy.
Main Results:
- MR imaging shows promise for non-invasive hepatic iron quantification.
- Significant variability exists in current MR techniques and calculation methods.
- Lack of standardization hinders widespread clinical adoption and inter-institutional comparison.
Conclusions:
- Magnetic Resonance is a viable non-invasive tool for assessing iron overload in Hereditary Hemochromatosis.
- Standardization of MR protocols and analysis is essential for clinical implementation.
- Further research is needed to establish reproducible and reliable MR-based hepatic iron quantification methods.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

